APA

Mattsson J., Ringdén O., Aschan J., Barkholt L., Dalianis T., Hägglund H., Ljungman P., Lönnqvist B., Tollemar J., Winiarski J. & Remberger M. (19970424). A low incidence of grade II to IV acute GVHD, but high mortality from infection using HLA-A, -B, and -DR-identical unrelated donors and immunosuppression with ATG, cyclosporine, and methotrexate. : Transplantation proceedings.

Chicago

Mattsson J, Ringdén O, Aschan J, Barkholt L, Dalianis T, Hägglund H, Ljungman P, Lönnqvist B, Tollemar J, Winiarski J and Remberger M. 19970424. A low incidence of grade II to IV acute GVHD, but high mortality from infection using HLA-A, -B, and -DR-identical unrelated donors and immunosuppression with ATG, cyclosporine, and methotrexate. : Transplantation proceedings.

Harvard

Mattsson J., Ringdén O., Aschan J., Barkholt L., Dalianis T., Hägglund H., Ljungman P., Lönnqvist B., Tollemar J., Winiarski J. and Remberger M. (19970424). A low incidence of grade II to IV acute GVHD, but high mortality from infection using HLA-A, -B, and -DR-identical unrelated donors and immunosuppression with ATG, cyclosporine, and methotrexate. : Transplantation proceedings.

MLA

Mattsson J, Ringdén O, Aschan J, Barkholt L, Dalianis T, Hägglund H, Ljungman P, Lönnqvist B, Tollemar J, Winiarski J and Remberger M. A low incidence of grade II to IV acute GVHD, but high mortality from infection using HLA-A, -B, and -DR-identical unrelated donors and immunosuppression with ATG, cyclosporine, and methotrexate. : Transplantation proceedings. 19970424.